Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI Doctor's helper: could a smart system improve heart and diabetes care?

NCT ID NCT07350486

Not yet recruiting Disease control Sponsor: First Hospital of China Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test whether an artificial intelligence (AI) system can help community doctors better manage patients who have high blood pressure along with diabetes or high cholesterol. About 6,800 adults will be split into two groups: one where doctors use the AI tool to guide treatment and follow-up, and another where they receive usual care. The goal is to see if the AI approach helps more patients reach healthy targets for blood pressure, blood sugar, and cholesterol.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Large language model (AI) software that helps community doctors coordinate care for multiple conditions
What this could lead to
If it works, this could show that AI-assisted community care improves control of blood pressure, blood sugar, and cholesterol in people with multiple conditions.
What could go wrong
This trial has not started yet and is testing a new AI system, so results are uncertain. The AI may not work as well in real-world community settings or may have technical issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus Dyslipidemias hypertensive disorder inherited lipid metabolism disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES DYSLIPIDEMIA HYPERTENSION

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The First Hospital of China Medical University

    Shenyang, Liaoning, 110001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.